omega-n-methylarginine has been researched along with incretins in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (incretins) | Trials (incretins) | Recent Studies (post-2010) (incretins) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 2,373 | 249 | 1,914 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, CN; Bharucha, AE; Camilleri, M; Charkoudian, N; Low, PA; Sletten, D; Zinsmeister, AR | 1 |
1 trial(s) available for omega-n-methylarginine and incretins
Article | Year |
---|---|
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Blood Glucose; Blood Pressure; Catecholamines; Enzyme Inhibitors; Female; Glucagon-Like Peptide 1; Heart Rate; Humans; Incretins; Male; Middle Aged; Muscle, Skeletal; Nitric Oxide; omega-N-Methylarginine; Parasympathetic Nervous System; Sympathetic Nervous System; Vasoconstriction; Yohimbine | 2008 |